SelfMade Health Network Announces Request for Proposals to Establish Regional Lead Organization to Support Southern Louisiana
March 23, 2016 11:41 ET
|
SelfMade Health Network
HAMPTON, Va., March 23, 2016 (GLOBE NEWSWIRE) -- As noted by the National Cancer Institute, "cancer health disparities" continue to exist among certain population groups and regions. These vulnerable...
Low Carbohydrate Diet Plan from Diet Doc Aims to Reduce Cancer Causing Carbohydrates in the Diet
March 10, 2016 04:06 ET
|
Diet Doc Diet and Weight Loss
PHILADELPHIA, March 10, 2016 (GLOBE NEWSWIRE) -- With new studies recently uncovering a connection between certain types of carbohydrates and lung cancer, Diet Doc has placed added emphasis on...
Patient Advocate Foundation Partners with Local Organizations to Provide Case Management Support to Underserved Individuals with Lung Cancer in West Virginia
February 29, 2016 05:21 ET
|
Patient Advocate Foundation
HAMPTON, Va., Feb. 29, 2016 (GLOBE NEWSWIRE) -- Patient Advocate Foundation (PAF), a national nonprofit dedicated to helping patients with serious illness access healthcare, has been awarded a...
The Forum of International Respiratory Societies Supports World Cancer Day on February 4
February 01, 2016 12:17 ET
|
American College of Chest Physicians
CAPE TOWN, GLENVIEW, LAUSANNE, MONTEVIDEO, NEW YORK, PARIS, TOKYO, Feb. 1, 2016 (GLOBE NEWSWIRE) -- In recognition of World Cancer Day on February 4, American College of Chest Physicians, alongside...
Peregrine Pharmaceuticals to Present at Two Upcoming Cancer Immunotherapy Conferences
January 20, 2016 08:05 ET
|
Peregrine Pharmaceuticals Inc.
TUSTIN, Calif., Jan. 20, 2016 (GLOBE NEWSWIRE) -- Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM) (NASDAQ:PPHMP), a biopharmaceutical company focused on developing therapeutics to stimulate the...
Peregrine Pharmaceuticals to Participate in Two Upcoming Life Science Investor Conferences
November 23, 2015 08:05 ET
|
Peregrine Pharmaceuticals Inc.
TUSTIN, Calif., Nov. 23, 2015 (GLOBE NEWSWIRE) -- Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM) (NASDAQ:PPHMP), a biopharmaceutical company focused on developing therapeutics to stimulate the...
AstraZeneca and Peregrine Pharmaceuticals Expand Ongoing Immuno-Oncology Collaboration to Include Phase II Lung Cancer Combination Clinical Trial
October 15, 2015 08:05 ET
|
Peregrine Pharmaceuticals Inc.
TUSTIN, Calif., Oct. 15, 2015 (GLOBE NEWSWIRE) -- Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM) (NASDAQ:PPHMP), a biopharmaceutical company focused on developing therapeutics to stimulate the...
University of Colorado Hospital Announces new Center for Lungs and Breathing
October 01, 2015 09:05 ET
|
UCHealth
AURORA, COLO., Oct. 1, 2015 (GLOBE NEWSWIRE) -- UCHealth's University of Colorado Hospital (UCH), a national leader in pulmonology, cancer and upper airway disorders, opens its new multidisciplinary...
Peregrine Pharmaceuticals Declares Quarterly Dividend On Its Series E Convertible Preferred Stock
September 08, 2015 16:05 ET
|
Peregrine Pharmaceuticals Inc.
TUSTIN, Calif., Sept. 08, 2015 (GLOBE NEWSWIRE) -- Peregrine Pharmaceuticals, Inc. (Nasdaq:PPHM) (Nasdaq:PPHMP) today announced that its Board of Directors has declared a quarterly cash dividend...
New Translational Data Highlights Bavituximab’s Ability to Induce Signs of Immune Activation in Lung Cancer Tumor Samples With Negative PD-L1 Expression
September 08, 2015 08:05 ET
|
Peregrine Pharmaceuticals Inc.
TUSTIN, Calif., Sept. 08, 2015 (GLOBE NEWSWIRE) -- Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM) (NASDAQ:PPHMP), a biopharmaceutical company focused on developing therapeutics to stimulate the...